Europe Platelet Rich Plasma Market

Platelet Rich Plasma Market (By Types: Pure-Platelet Rich Plasma, Leukocyte-Platelet Rich Plasma and Leukocyte-Platelet Rich Fibrin; By Origin: Autologous, Allogenic and Homologous; By Applications: Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery and Other Surgeries) - Europe Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2022

  • Rep Id : TMRGL4761
  • Published On : Jun 2015
  • No. of Pages : 89
  • Category : Healthcare

 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Secondary Research
      1.3.2 Primary Research
      1.3.3 Assumptions
1.4 List of Abbreviations
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Europe PRP Market (2013 & 2022) 
2.2 Europe PRP Market, by Types, 2013 (USD Million) 
2.3 Europe PRP Market, by Origin, 2013 (USD Million) 
2.4 Europe PRP Market, by Applications, 2013 (USD Million) 
2.5 Comparative Analysis: Europe PRP Market, By Country, 2013 & 2022 (Value %)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Value Chain Analysis
3.3 Regulatory Framework
3.4 Market Drivers
      3.4.1 Increasing cosmetic surgeries likely to accelerate market growth
      3.4.2 Technological advancements and regulatory approvals for new devices are contributing to the growth of the PRP market
3.5 Restraints
      3.5.1 Threat of therapy failure and disease transfer (in case of allogenic and homologous PRP) could restrain market growth
3.6 Opportunities
      3.6.1 Development of technologically advanced devices and new application areas of PRP technology would open new avenues
3.7 Reimbursement Scenario
3.8 Porter’s Five Forces Analysis of the Europe Platelet Rich Plasma (PRP) Market
      3.8.1 Bargaining power of suppliers
      3.8.2 Bargaining power of buyers
      3.8.3 Threat of substitutes
      3.8.4 Threat of new entrants
      3.8.5 Competitive rivalry
3.9 Market Attractiveness Analysis: Europe Platelet Rich Plasma (PRP) Market, by Country, 2013
3.10 Competitive Landscape
      3.10.1 Market Share Analysis, by Key Players: Europe Platelet Rich Plasma Market, 2013 (Value %)
 
Chapter 4 Europe Platelet Rich Plasma Market, by Origin
4.1 Overview
      4.1.1 Europe PRP Market Revenue, by Origin, 2012 – 2022 (USD Million) 
4.2 Average Pricing Analysis
4.3 Autologous Platelet-Rich Plasma
      4.3.1 Europe Autologous PRP Market Revenue, 2012 – 2022 (USD Million) 
4.4 Allogenic Platelet-Rich Plasma
      4.4.1 Europe Allogenic PRP Market Revenue, 2012 – 2022 (USD Million) 
4.5 Homologous  Platelet-Rich Plasma
      4.5.1 Europe Homologous PRP Market Revenue, 2012 – 2022 (USD Million) 
 
Chapter 5 Europe Platelet Rich Plasma Market, by Types
5.1 Overview
      5.1.1 Europe PRP Market Revenue, by Types, 2012 – 2022 (USD Million) 
5.2 Pure Platelet-Rich Plasma (P-PRP) 
      5.2.1 Europe Pure PRP Market Revenue, 2012 – 2022 (USD Million) 
5.3 Leukocyte-Rich Platelet-Rich Plasma (L-PRP) 
      5.3.1 Europe Leukocyte Rich PRP Market Revenue, 2012 – 2022 (USD Million) 
5.4 Pure Platelet-Rich Fibrin (P-PRF)/Leukocyte-Rich Platelet-Rich Fibrin (L-PRF) 
      5.4.1 Europe P-PRF/L-PRF PRP Market Revenue, 2012 – 2022 (USD Million) 
 
Chapter 6 Europe Platelet Rich Plasma Market, by Applications
6.1 Overview
      6.1.1 Europe PRP Market Revenue, by Applications, 2012 – 2022 (USD Million) 
6.2 Orthopedic
      6.2.1 Europe Orthopedic PRP Market Revenue, 2012 – 2022 (USD Million) 
6.3 Cosmetic Surgery
      6.3.1 Europe Cosmetic Surgery PRP Market Revenue, 2012 – 2022 (USD Million) 
6.4 General Surgery
      6.4.1 Europe General Surgery PRP Market Revenue, 2012 – 2022 (USD Million) 
6.5 Neurosurgery
      6.5.1 Europe Neurosurgery PRP Market Revenue, 2012 – 2022 (USD Million) 
6.6 Other Surgeries (Urology, Cardiothoracic, Oral & Maxillofacial and Periodontal) 
      6.6.1 Europe Other Surgeries PRP Market Revenue, 2012 – 2022 (USD Million) 
 
Chapter 7 Europe Platelet Rich Plasma Market, by Country
7.1 Overview
      7.1.1 Europe PRP Market Revenue, by Country, 2012 – 2022 (USD Million) 
7.2 U.K. 
      7.2.1 U.K. PRP Market Revenue, 2012 – 2022 (USD Million) 
7.3 Germany
      7.3.1 Germany PRP Market Revenue, 2012 – 2022 (USD Million) 
7.4 France
      7.4.1 France PRP Market Revenue, 2012 – 2022 (USD Million) 
7.5 Italy
      7.5.1 Italy PRP Market Revenue, 2012 – 2022 (USD Million) 
7.6 Spain
      7.6.1 Spain PRP Market Revenue, 2012 – 2022 (USD Million) 
7.7 Rest of Europe
      7.7.1 Rest of Europe PRP Market Revenue, 2012 – 2022 (USD Million) 
 
Chapter 8 Recommendations
8.1 Development of new PRP devices and discovery of new application areas would fuel the market growth
8.2 Commercialization and promotion of technologically advanced PRP devices to boost market growth
 
Chapter 9 Company Profiles
9.1 AdiStem Ltd. 
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Arthrex, Inc. 
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 Biomet, Inc. 
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies
      9.3.5 Recent Developments
9.4 DePuy Synthes, Inc. (DePuy Mitek Sports Medicine) 
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies
      9.4.5 Recent Developments
9.5 Glofinn Oy      
      9.5.1 Company Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies
      9.5.5 Recent Developments
9.6 Harvest Technologies Corp. 
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Business Strategies
      9.6.5 Recent Developments
9.7 Medira Ltd. 
      9.7.1 Company Overview
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies
      9.7.5 Recent Developments
9.8 Regen Lab S.A. 
      9.8.1 Company Overview
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies
      9.8.5 Recent Developments
9.9 Stryker Corporation
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies
      9.9.5 Recent Developments

List of Tables
 
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Europe PRP Market (2013 & 2020) 
TABLE 3 Europe PRP Market Revenue, by Origin, 2012 – 2022 (USD Million) 
TABLE 4 Comparative Analysis of Various PRP Products (Origin) 
TABLE 5 Europe PRP Market Revenue, by Types, 2012 – 2022 (USD Million) 
TABLE 6 Comparative Analysis of Various PRP Products (Types) 
TABLE 7 Europe PRP Market Revenue, by Applications, 2012 – 2022 (USD Million) 
TABLE 8 Europe PRP Market Revenue, by Country, 2012 – 2022 (USD Million) 

List of Figures
 
FIG. 1 Market Segmentation : Europe Platelet Rich Plasma (PRP) Market
FIG. 2 Europe PRP Market, by Types, 2013 (USD Million) 
FIG. 3 Europe PRP Market, by Origin, 2013 (USD Million) 
FIG. 4 Europe PRP Market, by Applications, 2013 (USD Million) 
FIG. 5 Comparative Analysis: Europe PRP Market, by Country, 2013 & 2022 (Value %)
FIG. 6 Value Chain Analysis for Platelet Rich Plasma Market
FIG. 7 Porter’s Five Forces Analysis: Europe Platelet Rich Plasma (PRP) Market
FIG. 8 Market Attractiveness Analysis: Europe PRP Market, by Country, 2013 Value (%)
FIG. 9 Market Share Analysis, by Key Players: Europe Platelet Rich Plasma Market, 2013 (Value %)
FIG. 10 Europe Autologous PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 11 Europe Allogenic PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 12 Europe Homologous PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 13 Europe Pure PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 14 Europe Leukocyte Rich PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 15 Europe P-PRF/L-PRF Market Revenue, 2012 – 2022 (USD Million) 
FIG. 16 Europe Orthopedic PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 17 Europe Cosmetic Surgery PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 18 Europe General Surgery PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 19 Europe Neurosurgery PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 20 Europe Other Surgeries PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 21 U.K. PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 22 Germany PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 23 France PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 24 Italy PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 25 Spain PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 26 Rest of Europe PRP Market Revenue, 2012 – 2022 (USD Million) 
FIG. 27 Biomet, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 
FIG. 28 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million)